Urokinase receptor: a molecular organizer in cellular communication.
about
Anthrax toxin receptor 1/tumor endothelium marker 8 mediates cell spreading by coupling extracellular ligands to the actin cytoskeletonInduction of apoptosis in vascular cells by plasminogen activator inhibitor-1 and high molecular weight kininogen correlates with their anti-adhesive propertiesIdentification and characterization of the endocytic transmembrane glycoprotein Endo180 as a novel collagen receptorSingle cell spectroscopy: noninvasive measures of small-scale structure and functionVEGF-initiated angiogenesis and the uPA/uPAR systemThe urokinase plasminogen activator receptor in the regulation of the actin cytoskeleton and cell motilityComputer aided identification of small molecules disrupting uPAR/alpha5beta1--integrin interaction: a new paradigm for metastasis preventionCaveolin-1 knockout mice show an impaired angiogenic response to exogenous stimuliIsothiocyanate-Functionalized Bifunctional Chelates and fac-[M(I)(CO)3](+) (M = Re, (99m)Tc) Complexes for Targeting uPAR in Prostate CancerModulation of cellular migration and survival by c-Myc through the downregulation of urokinase (uPA) and uPA receptorDependence on endocytic receptor binding via a minimal binding motif underlies the differential prognostic profiles of SerpinE1 and SerpinB2 in cancer.Binding of urokinase plasminogen activator to gp130 via a putative urokinase-binding consensus sequence.Random peptide bacteriophage display as a probe for urokinase receptor ligands.Plasmin cleaves the juxtamembrane domain and releases truncated species of the urokinase receptor (CD87) from human bronchial epithelial cells.Plasma levels of soluble urokinase-type plasminogen activator receptor (suPAR) and early mortality risk among patients enrolling for antiretroviral treatment in South Africa.In silico docking of urokinase plasminogen activator and integrins.Characterisation of urokinase plasminogen activator receptor variants in human airway and peripheral cells.Expression of uPAR in Urinary Podocytes of Patients with Fabry Disease.Cell adhesion regulates gene expression at translational checkpoints in human myeloid leukocytesThe fibrinolytic receptor for urokinase activates the G protein-coupled chemotactic receptor FPRL1/LXA4R.Assessment of Urokinase-Type Plasminogen Activator and Its Inhibitor PAI-1 in Breast Cancer Tissue: Historical Aspects and Future ProspectsMechanisms of tumour invasion and metastasis: emerging targets for therapy.Cathepsin B and uPAR knockdown inhibits tumor-induced angiogenesis by modulating VEGF expression in gliomaUrokinase and its receptors in chronic kidney disease.Nicotinic acetylcholine receptor α1 promotes calpain-1 activation and macrophage inflammation in hypercholesterolemic nephropathyMembrane associated proteases and their inhibitors in tumour angiogenesis.The Pseudomonas aeruginosa LasB metalloproteinase regulates the human urokinase-type plasminogen activator receptor through domain-specific endoproteolysisCaveolin-1, caveolae, and glioblastomaUrokinase-type plasminogen activator receptor (uPAR)-mediated regulation of WNT/β-catenin signaling is enhanced in irradiated medulloblastoma cells.GPI-anchored uPAR requires Endo180 for rapid directional sensing during chemotaxis.Satellite cells attract monocytes and use macrophages as a support to escape apoptosis and enhance muscle growth.Platelets in inflammation and atherogenesis.Urokinase plasminogen activator (uPA) and plasminogen activator inhibitor type-1 (PAI-1) in breast cancer - correlation with traditional prognostic factors.Tumor-associated proteolytic factors uPA and PAI-1: critical appraisal of their clinical relevance in breast cancer and their integration into decision-support algorithms.Perspectives on endothelial-to-mesenchymal transition: potential contribution to vascular remodeling in chronic pulmonary hypertension.Adhesive and proteolytic phenotype of migrating endothelial cells induced by thymosin beta-4.The cutting edge: membrane-anchored serine protease activities in the pericellular microenvironment.Sphingosine-1-phosphate and interleukin-1 independently regulate plasminogen activator inhibitor-1 and urokinase-type plasminogen activator receptor expression in glioblastoma cells: implications for invasivenessLigand-engaged urokinase-type plasminogen activator receptor and activation of the CD11b/CD18 integrin inhibit late events of HIV expression in monocytic cells.Cell migration in response to the amino-terminal fragment of urokinase requires epidermal growth factor receptor activation through an ADAM-mediated mechanism.
P2860
Q24292948-DBEB3E63-2701-41F5-A690-84C4373CC5A0Q24300523-F708EAF1-0328-40C6-929A-F6DE7E4E8AC3Q24322753-B5598048-ACCA-498B-9005-C96B2A03BC93Q27013014-AAA1609C-B2CC-4DB1-87A2-D7D526D71A16Q27025897-14CAB964-5F80-44F1-95AF-FC0F4F8CF4B0Q28212178-03EC4512-1FD2-4006-9CE7-6E7906412137Q28474854-37A27695-B830-4B8C-9901-B1146ED79EA0Q28587327-6490E9DA-16FD-413B-9E9C-E71C5B9E0E0CQ28821362-00494784-EBA9-48E4-ACEF-0B56B93E92D0Q30493647-F1970538-C44C-4B8D-851B-3448EFA5B2ADQ30502082-D245A379-FEBB-4E82-A2DA-C20E23847863Q30911713-2C862E9D-A13D-45CA-A93D-3D147FCFCB7AQ31047145-33399226-5017-45DA-A88B-AF2FA4F8894DQ31110978-6AFF3084-DAF9-461A-A1D1-7D39DF635F36Q33284948-3D32E9A0-A55B-44D2-8855-5121806C5ACFQ33326906-0004BF5F-1945-4506-A620-4C8F45DA65E8Q33488055-C97CF18B-A5D4-405C-B509-21312318C241Q33646324-EF23E257-4236-4373-B4F2-0615B7F62FB1Q33943133-5F80752F-E52D-400F-B053-F3ECE2B3AE4FQ34009345-CC408CD8-0E00-45E1-8AB8-BB858E19D2E6Q34095769-2D5E25AC-DD39-4DF5-B977-9C60F966027DQ34837655-189D1902-75DE-4FEB-876A-E3B7EF710D79Q34987834-2F34BD72-A5AC-465B-A823-BD36282799CFQ35124141-FE6B5AF9-3AA2-4A2F-8B03-17DAF5C77785Q35282636-FEF97DBF-2023-4198-BD09-27E0342FE8D3Q35587684-06967144-7D84-40C8-9FE3-6E9A61644665Q35949789-28530BE5-D058-4A70-9C63-A57D09B7C2B5Q36010112-976667F1-D2AF-45D8-B555-0965CECBEC08Q36016967-9C56F427-5F1C-4AB7-BCF0-195120E700B2Q36323266-C8FB50EA-E2E6-4A89-8252-DF3BC63D9D65Q36324730-18FF4FC8-575B-4168-A035-7CACB15285C2Q36328825-876C1009-FB3B-4289-8693-C93C3AFC146AQ36490382-F2E9E9BD-F627-45C1-9FB8-2C01EA39F451Q36761523-4F23EEC3-B78E-4FE0-923F-ACD179ABA5A1Q36769644-5447A1AC-5ACA-444E-98AB-47496652797AQ36818204-E0FC90BC-68C1-4E17-AD7C-3F5CA627594BQ36923138-58B06EC8-E78F-494E-8A2E-52949430F9CBQ36982983-649D987C-C488-4307-A58B-B99B72A3EA32Q37109384-F3DA87B6-B533-4DD1-8745-C745D53E799FQ37215257-875066C7-1C43-4502-841A-0F77D487109F
P2860
Urokinase receptor: a molecular organizer in cellular communication.
description
2000 nî lūn-bûn
@nan
2000 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Urokinase receptor: a molecular organizer in cellular communication.
@ast
Urokinase receptor: a molecular organizer in cellular communication.
@en
Urokinase receptor: a molecular organizer in cellular communication.
@nl
type
label
Urokinase receptor: a molecular organizer in cellular communication.
@ast
Urokinase receptor: a molecular organizer in cellular communication.
@en
Urokinase receptor: a molecular organizer in cellular communication.
@nl
prefLabel
Urokinase receptor: a molecular organizer in cellular communication.
@ast
Urokinase receptor: a molecular organizer in cellular communication.
@en
Urokinase receptor: a molecular organizer in cellular communication.
@nl
P1476
Urokinase receptor: a molecular organizer in cellular communication
@en
P2093
K T Preissner
P304
P356
10.1016/S0955-0674(00)00141-1
P577
2000-10-01T00:00:00Z